Journal For Clinical Studies
Journal For Clinical Studies

SEARCH

MEDIA PACK
NEWS

MENU

Current Edition

 
Custopharm

Hikma bolsters injectables franchise with $425M deal for Custopharm, but FTC review looms

Generics giant Hikma is boosting its injectables business to nearly 130 products in the U.S. by way of dealmaking. For $375 million upfront and another …

29 September 2021 Regional News Custopharm Federal Trade Commission
Continue Reading →
 
jcs-white

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Twitter Linkedin
Journal For Clinical Studies © 2022, All Rights Reserved – Powered by Teksyte